BRIEF-Revolution Medicines Q1 EPS USD -1.13

Reuters
08 May
BRIEF-Revolution Medicines Q1 EPS USD -1.13

May 07 (Reuters) - Revolution Medicines Q1 operating expenses USD 240.76 million.

  • Q1 net income USD -213.416 million
  • Q1 operating income USD -240.76 million
  • outlook FY net income USD -900 to -840 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10